CORCEPT THERAPEUTICS INC - Common Stock (CORT)
CUSIP: 218352102
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 105,274,735
- Total 13F shares
- 89,585,381
- Share change
- +1,313,046
- Total reported value
- $1,506,658,948
- Put/Call ratio
- 48%
- Price per share
- $16.82
- Number of holders
- 215
- Value change
- +$28,288,519
- Number of buys
- 116
- Number of sells
- 91
Quarterly Holders Quick Answers
What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 218352102:
Top shareholders of CORT - CORCEPT THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
14%
|
15,244,767
|
$181,259,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
11,117,827
|
$132,191,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
7.9%
|
8,302,841
|
$98,721,000 | — | 31 Mar 2020 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
7.6%
|
8,003,723
|
$95,164,000 | — | 31 Mar 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
5%
|
5,216,832
|
$62,028,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
3,174,603
|
$37,746,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
2,570,610
|
$30,563,000 | — | 31 Mar 2020 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1.8%
|
1,883,624
|
$22,396,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,479,261
|
$17,587,000 | — | 31 Mar 2020 | |
| Parallel Advisors, LLC |
13F
|
Company |
1.3%
|
1,405,895
|
$16,716,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
1,365,987
|
$16,241,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,311,018
|
$15,588,000 | — | 31 Mar 2020 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.1%
|
1,185,737
|
$14,098,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
1,162,862
|
$13,827,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
1%
|
1,055,507
|
$12,550,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.84%
|
883,545
|
$10,505,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.82%
|
862,130
|
$10,251,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.79%
|
836,256
|
$9,943,000 | — | 31 Mar 2020 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.76%
|
797,253
|
$9,479,000 | — | 31 Mar 2020 | |
| Man Group plc |
13F
|
Company |
0.71%
|
751,707
|
$8,938,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.66%
|
691,380
|
$8,221,000 | — | 31 Mar 2020 | |
| AJ WEALTH STRATEGIES, LLC |
13F
|
Company |
0.63%
|
668,020
|
$7,943,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.61%
|
643,135
|
$7,647,000 | — | 31 Mar 2020 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.6%
|
632,799
|
$7,524,000 | — | 31 Mar 2020 | |
| Matarin Capital Management, LLC |
13F
|
Company |
0.59%
|
623,915
|
$7,418,000 | — | 31 Mar 2020 | |
| S&T BANK/PA |
13F
|
Company |
0.56%
|
588,620
|
$6,999,000 | — | 31 Mar 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.51%
|
538,555
|
$6,403,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.5%
|
526,395
|
$6,259,000 | — | 31 Mar 2020 | |
| AJO, LP |
13F
|
Company |
0.49%
|
515,311
|
$6,127,000 | — | 31 Mar 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.48%
|
501,139
|
$5,958,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.48%
|
501,067
|
$5,957,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.47%
|
498,130
|
$5,923,000 | — | 31 Mar 2020 | |
| Jupiter Investment Management Ltd |
13F
|
Company |
0.46%
|
481,848
|
$5,729,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.33%
|
351,272
|
$4,180,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
351,337
|
$4,177,000 | — | 31 Mar 2020 | |
| OXFORD FINANCIAL GROUP, LTD. LLC |
13F
|
Company |
0.32%
|
332,436
|
$3,953,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.3%
|
317,583
|
$3,776,000 | — | 31 Mar 2020 | |
| AVIVA PLC |
13F
|
Company |
0.3%
|
316,843
|
$3,767,000 | — | 31 Mar 2020 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
302,634
|
$3,598,000 | — | 31 Mar 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.28%
|
296,437
|
$3,525,000 | — | 31 Mar 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.27%
|
284,237
|
$3,380,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.26%
|
272,020
|
$3,234,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.24%
|
254,123
|
$3,022,000 | — | 31 Mar 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.23%
|
237,587
|
$2,825,000 | — | 31 Mar 2020 | |
| MACKAY SHIELDS LLC |
13F
|
Company |
0.23%
|
236,900
|
$2,817,000 | — | 31 Mar 2020 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.23%
|
238,815
|
$2,816,000 | — | 31 Mar 2020 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.22%
|
230,409
|
$2,740,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.21%
|
218,143
|
$2,594,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.2%
|
213,196
|
$2,535,000 | — | 31 Mar 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.2%
|
209,029
|
$2,486,000 | — | 31 Mar 2020 |
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2020
As of 30 Jun 2020,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,585,381 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, INGALLS & SNYDER LLC, FEDERATED HERMES, INC., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, LSV ASSET MANAGEMENT, GEODE CAPITAL MANAGEMENT, LLC, and NORGES BANK.
This page lists
215
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
198
Q2 2020 holders
215
Holder diff
17
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.